Enzastaurin for Patients With Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
Enzastaurin given daily to participants with colorectal cancer who have Stage 4 disease and
have not received prior chemotherapy for advanced colorectal cancer